Nutritional status changes in HIV-infected children receiving combined antiretroviral therapy including protease inhibitors

International Journal of Antimicrobial Agents

Volumn 16, Issue 3, 2000, Pages 365-369

  Fiore, Paolo ^a   Donelli, Emanuela ^b   Boni, Silvia ^b   Pontali, Emanuele ^b   Tramalloni, Roberto ^a   Bassetti, Dante ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Children; HIV; Nutritional status; Protease inhibitors; Therapy

Indexed keywords

ANTIRETROVIRUS AGENT; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR;

ANTHROPOMETRY; ARTICLE; CALORIC INTAKE; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LIPID METABOLISM; LONGITUDINAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; QUALITY OF LIFE; VIRUS LOAD; WEIGHT GAIN;

ADOLESCENT; ANTI-HIV AGENTS; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INFANT; LIPID METABOLISM; LONGITUDINAL STUDIES; MALE; NUTRITIONAL STATUS;

EID: 0033727644     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00266-1     Document Type: Article

References (26)

1. Nutritional aspects of HIV infection
2. Lean body wasting and therapeutic implications of altereted metabolism in AIDS
3. Effect of malnutrition on the progression of AIDS
4. The HIV wasting syndrome: A review
5. Nutrition support of the pediatric patients with AIDS
6. Gastrointestinal and nutritional problems in pediatric HIV-disease
7. Growth and body composition in children infected with the human immunodeficiency virus-1
8. Abnormalities in growth and development
9. Acquired immune deficiency-syndrome in infants
10. Effect of human immunodeficiency virus infection on the growth of young children
11. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
12. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
13. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
14. Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients
15. Effect of indinavir on HIV-related wasting
16. The effect of protease inhibitors on weight and body composition in HIV-infected patients
17. Protease inhibitor therapy in children with perinatally acquired HIV infection
18. A phase I/II study of the protease inhibitor indinavir in children with HIV infection
19. Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: Experience with fifty-four perinatally infected children
20. Preliniminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children
21. Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus
22. Ritonavir promotes increased growth in HIV-infected children
23. Italian guidelines for antiretroviral therapy in children with human immunodeficiency virus-type 1 infection
24. Anthropometric assessment